to the task force of the California Health Benefits Review Program of the state legislature and served on the Advisory Group on Pain Assessment and Management in Long-Term Care Settings for the Joint Commissions. He has been involved in national quality metrics development on long-term care and transitions of care with prior service on the Pharmacy Quality Alliance (PQA). He has served on the American Academy of Neurology Neurotherapies Workgroup on Pharmacoeconomics. He received a B.S. from the University of Washington, Pharm.D. from the University of Southern California, and M.S. and Ph.D. from the University of Washington Comparative Health Outcomes, Policy, and Economics Institute.

Oluwaranti “Ranti” Akiyode, Pharm.D., serves as the dean and professor of pharmacy practice at the Howard University College of Pharmacy, leveraging over 23 years of academic experience in clinical pharmacy practice, pharmacy student recruitment and admissions, and the delivery of exceptional pharmacy education. A board-certified pharmacotherapy specialist, she is recognized for her expertise in diabetes care and education. Her commitment to excellence is demonstrated through numerous accolades, including the DC Diabetes Educator of the Year Award, Innovative Pharmacy Practice Award, and Faculty Preceptor of the Year Award. Dr. Akiyode also serves on the Walgreens Dean’s Advisory Council, an initiative aimed at enhancing the pharmacy profession and better supporting pharmacists in patient care. She holds a doctorate in clinical pharmacy from the University of Mississippi School of Pharmacy and completed a community pharmacy residency at Leesburg Pharmacy. In 2021, she furthered her leadership development by completing the American Association of Pharmacy Academic Leadership Fellowship Program, reaffirming her dedication to lifelong learning and leadership in higher education.

M. Thomas Bateman, Jr., Pharm.D., BCACP, is a board-certified ambulatory care pharmacist. He is a clinical assistant professor at the Ernest Mario School of Pharmacy at Rutgers, the State University of New Jersey. He serves as the lead clinical pharmacist of Henry J. Austin Health Center, a federally qualified health center in Trenton, NJ, and the residency program director for its PGY2 Ambulatory Care Residency Program. Dr. Bateman is a graduate of Philadelphia College of Pharmacy and completed pharmacy practice residencies in community practice and ambulatory care. His passion is working with underserved, urban communities, and he has published multiple papers, mainly about the pharmacist’s role in chronic disease management in the outpatient setting. Dr. Bateman serves as the chair-elect of the American Pharmacists Association’s (APhA’s) Care of Underserved Patients Special Interest Group. He spoke as an invited panelist of the National Academies workshop on Addressing Workforce Challenges Across the Behavioral Health Continuum of Care.

Chalmers Distinguished Pharmacy Educator Award from the American Association of Colleges of Pharmacy (AACP). She has a Pharm.D., M.P.H., M.B.A., and D.Phil. in health sciences.

Suzanne Harris, Pharm.D., BCPP, CPP, is an associate professor in the Division of Practice Advancement and Clinical Education and director of Well-Being and Resilience at the UNC Eshelman School of Pharmacy and a board-certified psychiatric pharmacist in a consult liaison psychiatric clinic. Dr. Harris’ career and research interests are focused on stigma and mental health and their relation to overall well-being in the pharmacy profession, cultural competency, and social determinants of health for patients with psychiatric disorders, and innovative practice models and teaching strategies. She is an active member of the American Association of Psychiatric Pharmacists and its 2025 president-elect. Dr. Harris was on the 2024–2025 Student Affairs Committee for AACP and is a member of the AACP Well-Being Community. She received a Pharm.D. in 2002 from the University of Texas College of Pharmacy at Austin and completed a psychiatric specialty residency with Kaiser Permanente Colorado Region in Denver, Colorado.

S. Claiborne “Clay” Johnston, Ph.D., M.D., M.P.H., is the cofounder and chief medical officer for Harbor Health, a health insurer and multispecialty clinic that is creating a true learning health system. He was the inaugural dean of the Dell Medical School at the University of Texas at Austin, where he sought to build a world-class medical school via a vital, inclusive health ecosystem that supports new and innovative models of education, health care delivery, and discovery—all with a focus on improving health and making Austin a model healthy city. Dr. Johnston is also a neurologist, specializing in stroke care and research. He was at UCSF, where he served as associate vice chancellor of research and founding director of the Center for Healthcare Value. He graduated from Amherst College, completed medical school at Harvard University, and received a Ph.D. in epidemiology from the University of California Berkeley. He is a member of NAM and has served on several committees, including the Drug Forum.

Dawn Kashelle Lockman, Pharm.D., M.A., is a clinical associate professor in the Office of Consultation and Research in Medical Education, Department of Internal Medicine, at University of Iowa Carver College of Medicine. Earlier, she was faculty at University of Iowa College of Pharmacy for 8 years in the SOLACE Palliative Care Collaborative, where she codesigned and directed a palliative care certificate and practiced as a palliative care pharmacist within the Iowa Healthcare interprofessional team. Her work focuses on competency-based education, entrustable professional activities, strategies to teach whole-person care, and strategies to foster belonging and

well-being in health professions education and practice. Dr. Lockman serves as president-elect for the Society of Pain and Palliative Care Pharmacists and represents it on the National Academies Roundtable on Quality Care for People with Serious Illness. She is a 2019 Cambia Health Foundation Sojourns Scholar and has received several teaching awards, including the 2019 American College of Clinical Pharmacy (ACCP) New Educator of the Year. She earned a B.S. in biology at the College of Charleston, Pharm.D. from the University of Maryland, and M.A. in instructional systems development from University of Maryland, Baltimore County.

Leigh Ann Ross, Pharm.D., FCCP, BCPS, is the dean and Bell Endowed Chair at Auburn University Harrison College of Pharmacy. Earlier, she held several key positions at the University of Mississippi School of Pharmacy (UMSOP), including associate dean for clinical affairs, director of the Center for Clinical and Translational Science, and chair of the Department of Pharmacy Practice. She also served as a professor at the John D. Bower School of Population Health at the University of Mississippi Medical Center (UMMC). Dr. Ross earned a B.B.A. in finance and Pharm.D. from Ole Miss, followed by a primary care pharmacy residency at UMMC. She joined UMSOP in 1999, where she spearheaded medication management (MM) services. Additionally, she completed a Congressional Fellowship with U.S. Senator Thad Cochran, advising on health care and economic policies. Dr. Ross has held leadership roles in numerous professional organizations, including president of the ACCP, Mississippi Pharmacists Association, and Mississippi Biotechnology Association and chair of Pharmacotherapy Publications, Inc. and the ACCP Political Action Committee Governing Council. She is a fellow of ACCP, ASHP, APhA, and NAP.

NAM FELLOWS

Jennifer Bacci, Pharm.D., M.P.H., BCACP, FCCP, is the endowed associate professor in innovative pharmacy practice and codirector of the Center for Pharmacy Practice Transformation at the University of Washington School of Pharmacy. She serves as a network facilitator for CPESN WA, a clinically integrated network of community pharmacies in the state of Washington, and a leader in the ACT Collaborative, a group of faculty nationwide who partner with community pharmacies to advance practice. Her research applies implementation science to evaluate and advance patient care models in community pharmacy practice. Her work includes investigating the implementation of patient care services at the practice level and policies that affect their delivery and the community pharmacy workforce. She has published on a range of community pharmacy services, including adult and pediatric vaccinations and medications for opioid use disorder. Dr. Bacci

completed a Pharm.D. at the University of Pittsburgh School of Pharmacy and community-based pharmacy residency with Rite Aid and the university. After working in community practice, she returned to the University of Pittsburgh to complete a postgraduate fellowship in community pharmacy research and an M.P.H. She is a recipient of the Albert B. Prescott Pharmacy Leadership Award and Washington State Distinguished Young Pharmacist of the Year Award. She is a board-certified ambulatory care pharmacist and ACCP fellow.

WORKSHOP SPEAKERS

Paul W. Abramowitz, Pharm.D., has been CEO of the American Society of Health-System Pharmacists and president of its foundation for the past 14 years. Earlier, he worked in hospitals and health systems for over 30 years. He served as associate hospital director for professional services and chief pharmacy officer at the University of Iowa Hospitals and Clinics and professor at the University of Iowa College of Pharmacy. He also held positions as director of pharmacy and associate professor at the Medical College of Virginia and University of Minnesota. He has actively combined practice, teaching, and research throughout his career. He has lectured and published extensively, focusing on the effect of quality pharmacy care on improving outcomes and reducing costs, developing new pharmacy care models, reducing adverse drug events, and expanding comprehensive medication management (CMM) to all sites of care. He received the John W. Webb Lecture Award in 2000 and Harvey A.K. Whitney Lecture Award in 2009, health-system pharmacy’s highest honor. He serves on the boards of the American Nurses Foundation, Pharmacy Technician Certification Board, GTMRx Institute, and Howard University College of Pharmacy board of visitors. He is also a member of the National Steering Committee for Patient Safety of the Institute for Healthcare Improvement and professor emeritus at the University of Iowa.

Rafael Alfonso-Cristancho, M.D., Ph.D., M.Sc., is a renowned global leader in real-world evidence (RWE) and health economics and outcomes research (HEOR). With an extensive and impactful career, he has been instrumental in developing evidence-generation strategies that have significantly influenced clinical development, regulatory approvals, and reimbursement policies for several therapies, including multi-indication blockbusters. His academic and professional journey has seen him lead numerous global, regional, and local initiatives at top pharmaceutical companies, such as GlaxoSmithKline, Sanofi, and Merck. His leadership and strategic insights have advanced the field of HEOR and RWE, positioning these companies at the forefront of health care innovation. In addition to his corporate

achievements, Dr. Alfonso-Cristancho has served as a respected faculty member at prestigious academic institutions. His dedication to education and mentorship has shaped the careers of many future leaders in clinical development and health economics. Recognized as a pioneering researcher and innovator, he has expertise spanning comparative effectiveness, cost-effectiveness modeling, and real-world data analytics. His work has driven health care innovation and evidence-based decision making on a global scale, improving patient outcomes and influencing policy decisions worldwide. He holds an M.D., a Ph.D. in pharmaceutical outcomes research, and an M.Sc. in pharmacoepidemiology.

Mark Atalla, Pharm.D., M.B.A., served as a senior advisor to the Centers for Medicare & Medicaid Services (CMS) administrator for prescription drug policy and innovation. He was also responsible for creating multiple new payment models at the CMS Innovation Center, including the Part D Senior Savings Model to lower the cost of insulin in Medicare, Part D Payment Modernization Model that created a blueprint for broader Part D redesign, and second-generation MA Value-Based Insurance Design Model. He also served as a senior advisor to the Department of Health and Human Services (HHS) and Department of Defense leadership for Operation Warp Speed during the COVID-19 public health emergency. Most recently, he has worked to apply generative AI and other novel technologies and devices to manage financial risk contracts in value-based frameworks. He has broad pharmacy experience, spanning community, specialty, and pediatric hospital pharmacy, and pharmacy benefit management leadership. He volunteers as a clinical professor at the UCSF School of Pharmacy and on the Dean’s Leadership Council at the University of Florida College of Pharmacy. He has a Pharm.D. from the University of Florida and M.B.A from Yale University.

Amanda Brummel, PharmD, BCACP, serves as the vice president of clinical ambulatory pharmacy services. She has been employed by Fairview Pharmacy Services since 1999, when she graduated from the University of Minnesota. She has built and practiced CMM as a part of MHealth Fairview’s MTM Program in multiple clinic locations. Dr. Brummel has responsibility for the network’s MTM Program, Anticoagulation Program, Outcomes Department, and clinical development and integration of ambulatory pharmacy services, including transitions of care and quality measurement. She works closely with the network on population health approach and new payer product development. Dr. Brummel is also an adjunct professor at the University of Minnesota. She has published multiple articles on MTM and pharmacy’s role in the care team.

a consultant to the Accreditation Council for Pharmacy Education (ACPE) for the International Services Program. He was editor for Pharmacotherapy: A Pathophysiologic Approach for 12 editions, ASHP’s Pharmacy Forecast for 6 years, and American Journal of Pharmaceutical Education for 12 years. He is also the author of Concepts in Clinical Pharmacokinetics and editor of Encyclopedia of Clinical Pharmacy. He has published over 250 papers and editorials in academic and professional journals and books and book chapters.

Kathy Giacomini, Ph.D., B.S.Pharm, is dean and Troy C. Daniels Distinguished Professor of Pharmaceutical Sciences and associate vice chancellor of pharmacy affairs at UCSF. A world-renowned scientist in the field of membrane transporters, she is widely recognized for her work on transporter genomics and pharmacogenomics. Her research has revealed the molecular identity and functional roles of human drug transporters and effects of genetic polymorphisms on function and clinical drug response. Dr. Giacomini is co-principal investigator of the UCSF-Stanford Center of Excellence in Regulatory Science and Innovation, a Food and Drug Administration- (FDA-)supported center focused on addressing key challenges related to education and research and advancing scientific issues related to the safe and effective use of medical products. She was president of the American Society for Clinical Pharmacology and Therapeutics and on the editorial board and is the deputy editor of its journal. Dr. Giacomini has served on the National Institute of General Medical Sciences Pharmacological Sciences Study Section and its National Advisory Council and the FDA Advisory Panel on Clinical Pharmacology. As dean, she brings her expertise and background in pharmacy to support groundbreaking research, individualized patient care, and unparalleled and innovative education programs. She has received numerous awards for her scientific accomplishments and is an elected member of NAM and the American Academy of Arts and Sciences.

Laura Hanson, Pharm.D., M.B.A., B.C.P.S., is the ambulatory pharmacy manager at Virginia Mason Medical Center (VMMC) in Seattle, Washington. She has oversight of the embedded clinical pharmacists located in primary care and specialty clinics, centralized refill authorization, prior authorization, and population health services. She also serves as the director for VMMC’s PGY1 Pharmacy Residency Program and clinical coordinator for the PGY2 Ambulatory Pharmacy Residency Program. She is a board-certified pharmacotherapy specialist with over 26 years of experience in clinical practice and ambulatory care pharmacy. Dr. Hanson is a graduate of Idaho State University and has completed a PGY1 pharmacy practice residency at the University of Washington Medical Center and PGY2 primary care residency at Harborview Medical Center. As a pharmacy leader

in Washington State, she implemented professional billing in her clinic practices. She is passionate about creating sustainable models and advancing pharmacy practice. She has been actively involved at both the state and national levels promoting the role of the pharmacist on the health care team. She is an active member of the American Society of Health System Pharmacy Special Advisory Group for Clinical Practice Advancement and has served in leadership roles for the Washington State Pharmacy Association. She is on the American Medical Association CPT Advisory Committee as a pharmacist member of the Health Care Professionals Advisory Committee.

Michael D. Hogue, Pharm.D., FAPhA, FNAP, FFIP, is the 15th executive vice president and CEO of APhA as of 2023. He has 30 years of experience in community practice as both a pharmacy owner and a staff pharmacist and an ambulatory care provider in family and preventive medicine. He is an accomplished academician, having served on the faculty at Samford University and Loma Linda University. Earlier, Dr. Hogue was the dean of pharmacy at Loma Linda University with faculty appointments in the schools of pharmacy and medicine and director of interprofessional education and practice; he launched a comprehensive pharmacotherapy clinic in collaboration with the Faculty Medical Group. He served on the development team for the APhA Pharmacy-Based Immunization Delivery national certificate program for pharmacists and pharmacy technicians, the U.S. education standard. Dr. Hogue was the first pharmacist appointed by the Centers for Disease Control and Prevention (CDC) to serve on its COVID19 vaccine workgroup in April 2020 and APhA’s liaison representative to the American Committee on Immunization Practices (ACIP) 2020–2023. He also served on the ACIP Adult RSV Vaccine Workgroup. Dr. Hogue was inducted into the Alabama Healthcare Hall of Fame in 2018 and Alabama Pharmacy Hall of Fame in 2024 for decades of work in improving immunization rates among residents of the state through pharmacies. He was the first Alabama immunizing pharmacist in a community pharmacy in 1997.

Samuel G. Johnson, Pharm.D., serves as the vice president of medication solutions (since 2021) for the Craneware Group, a technology company dedicated to developing software solutions that optimize financial and operational outcomes for U.S. health-system pharmacies. Earlier, Dr. Johnson was the associate executive director for the Board of Pharmacy Specialties (BPS) in Washington, DC, where he helped establish and lead interprofessional engagement and research efforts to optimize the value and impact of pharmacist board certification. He was the director of health policy and interprofessional affairs for ACCP, where he led the work in analyzing, developing, implementing, and promoting policies and programs to advance clinical pharmacy and its practitioners in progressive health care

delivery systems at the national level. He received a B.S. in biology from Truman State University in Kirksville, MO, and Pharm.D. from the University of Missouri Kansas City School of Pharmacy. He also completed a specialty residency in cardiology with the Kaiser Permanente Colorado Region in Denver, CO. He is BPS board certified in pharmacotherapy and held BPS added qualifications in cardiology. In 2012, he was selected as the inaugural NAM Anniversary Fellow in Pharmacy, where he contributed to the work of the Consensus Committee on Core Metrics for Better Health at Lower Cost and Roundtable on Translating Genomic-based Research for Health. He served on the Colorado Pharmacists Society board of directors (2013–2015) and as its president-elect (2015).

Mary Ann Kliethermes, Pharm.D., is senior director of medication safety and quality at ASHP. Her major projects are Standardize 4 Safety and updating the antimicrobial surgical prophylaxis guidelines. Her expertise is in pharmacist reimbursement, medication optimization, safety and quality associated with pharmacist services in new health care models, and value-based payment systems. Her career began with institutional practice, which included developing clinical pharmacy services, including medicine and critical care practice; and pharmacokinetic dosing, nutritional support, and adverse drug event reporting in pharmacist services. Through part ownership of a home infusion company, she developed innovative clinical pharmacy services around antibiotic therapy, nutritional support, and adverse drug events. As a consultant for the Illinois Pharmacy Foundation, she developed the state pharmacist immunization program in the early 1990s. In 2001, she was manager of the MTM Clinic at the University of Illinois Chicago, developing and expanding it while serving patients with multiple conditions and multiple medications to optimize medication therapy through CMM services. In 2008, she was vice chair of ambulatory care at the Chicago College of Pharmacy, Midwestern University and earned tenured professor status. She was chair of the Section of Home, Ambulatory, and Chronic Care for ASHP and represented it for the Joint Commission, the Physician Consortium for Performance Improvement, and CMS. She was involved with PQA since its inception, including serving as board chair. She was chair of the PCMH/ACO SIG for the American Pharmacist Association and represented pharmacy at the ASPE Patient Safety Events in Ambulatory Care Settings Technical Expert Panel. Her awards include Pharmacist of the Year, Shining Star Award, and Amy Lodolce Mentorship Award from ICHP; Distinguished Service Award and Distinguished Leadership in Health-System Pharmacy Practice from ASHP; CCP Outstanding Faculty Award; and Daniel B. Smith Practice Excellence award from APhA. She graduated from University of Michigan with a B.S. in pharmacy and Philadelphia College of Pharmacy and Science with a Pharm.D.

He is board certified in geriatrics and as a pharmacotherapy specialist. His areas of interest include community-based outcomes research, student development, residency training, geriatrics, new business models for service delivery, and developing and implementing patient care services. Dr. McDonough has published and presented extensively on pharmaceutical care, MTM, and implementing patient care services in the community pharmacy setting. He is recognized for his efforts in developing and implementing new pharmacy business models. He has coauthored a book on pharmaceutical care and written chapters for several other texts. He has presented nationally and internationally and been recognized for his work with the APhA Daniel B. Smith Award, the National Community Pharmacists Association (NCPA) Independent Pharmacist of the Year, the Independent Pharmacy Alliance (IPA) Innovative Pharmacist of the Year, and Parata’s Lifetime Achievement, Entrepreneurial, and Patient Care Pharmacist of the Year Awards. He is APhA president for 2025–2026.

Melissa Somma McGivney, Pharm.D., FCCP, FAPhA, is committed to advancing pharmacist-provided patient care and inspiring the next generation of student pharmacist leaders. She is professor and associate dean for student success and professional initiatives at the University of Pittsburgh School of Pharmacy. She collaboratively developed patient care practices in family medicine, chain, and independent pharmacies and most recently the university’s mass vaccination and preventive health services. She has fostered novel partnerships between academia, community pharmacies (independent and chain), state and local health departments, professional associations, and health payers supporting the development and payment for pharmacist-provided patient care. She is skilled at bringing people together to collaboratively solve problems, build programs, and advocate for the betterment of the profession and patient care. She is a founding board member of the Pennsylvania Pharmacists Care Network/CPESN, with over 200 community pharmacies. She directs the ACT Pharmacy Collaborative of faculty from 112 colleges/schools of pharmacy and was a PGY1 community-based residency director for 15 years. She is an elected APhA board of trustees member-at-large 2024–2027 and on the inaugural Walgreens Deans Advisory Council. At Pitt, she is APhA-Academy of Student Pharmacists faculty advisor and an active member of the Pennsylvania Pharmacists Association, AACP, and ACCP. She is a frequent speaker and contributor to association programs. She received her Pharm.D. from the University of Pittsburgh and completed an ambulatory care residency at UPMC Presbyterian/University of Pittsburgh. She joined the Pitt Pharmacy faculty in 2003 after faculty appointments at Wilkes University Nesbitt School of Pharmacy and UPMC St. Margaret Family Medicine Residency Program.

at the UW Hospital and Clinics and served a fellowship in medical technology assessment at the University Healthsystem Consortium (now Vizient). He received the Winston J. Durant Lecture Award from UW, Willis G. Gregory Memorial Award from the University at Buffalo School of Pharmacy and Pharmaceutical Sciences, and Donald E. Francke Medal from ASHP.

Lorri Walmsley, R.Ph., FAzPA, is the director of pharmacy affairs for Walgreens’ Enterprise Pharmacy Practice team. A passionate community pharmacist for her entire career, she is the liaison with boards of pharmacy in the western third of the United States, where she is responsible for providing feedback on proposed rules and boards’ activities and working with other interested parties on pharmacy practice-related matters. She serves as the vice chair of the recently formed Walgreens Deans Advisory Council, which collaborates with academia to evolve the community pharmacy business model and enhance the pipeline of talent into colleges of pharmacy to ensure a stable supply of qualified pharmacists. She is on the Arizona Board of Pharmacy since 2018 and the acting president. During her tenure with the board, she has been a member of the National Association of Boards of Pharmacy, serving on many committees and task forces and as the current chair of NABP, District 8. A career-long member of APhA and the Arizona Pharmacy Association, she has held numerous roles in both organizations, including president of the latter (2017–2018). She serves on the APhA Government Affairs Committee. She is a fellow of the Arizona Pharmacy Association and received the 2016 AmerisourceBergen Incoming President’s Award, 2016 NCPA Pharmacy Leadership Award, and Arizona Pharmacy Association’s Outstanding Leadership Award (2017) and Pharmacist of the Year Award (2019).

Krystalyn Weaver, Pharm.D., J.D., is the executive vice president and CEO of the National Alliance of State Pharmacy Associations. She has focused on pharmacy advocacy, policy development, and regulatory affairs, working to enhance pharmacists’ prescriptive authority and improve patient care through increased access to pharmacist services. Before that, Dr. Weaver served as an associate at Sidley Austin LLP, counseling pharmaceutical and pharmacy clients on regulatory and enforcement matters. She holds a Pharm.D. from the University of Toledo and J.D. from George Mason University’s Antonin Scalia Law School. She and her family live in Alexandria, Virginia.

Sharon L. Youmans, Pharm.D., M.P.H., FAPhA, is a professor of clinical pharmacy and executive vice dean at the UCSF School of Pharmacy and associate dean for DEIB at the UCSF School of Dentistry. Dr. Youmans received a Pharm.D. from UCSF in 1985 and completed a pharmacy

practice residency in 1986. She has served as a clinical pharmacist in both inpatient and community pharmacy settings with specialty training in pediatrics. In 2001, Dr. Youmans joined the faculty at UCSF. In 2005, she received an M.P.H. with an emphasis in community health education from San Jose State University. In 2007, she was appointed vice chair of education for the Department of Clinical Pharmacy. In 2013, she became vice dean of the School of Pharmacy and oversaw the doctor of pharmacy program. In 2018, she became a member of the UCSF Haile T. Debas Academy of Medical Educators. In 2022, she was appointed executive vice dean, an advisor to the dean on the school’s strategic plans; diversity, equity, and inclusion (DEI) initiatives; special education projects; and fundraising. Dr. Youmans is a staunch advocate and champion of justice and DEI initiatives at UCSF and received the Chancellor’s MLK, Jr. Leadership Award and ASHP Association of Black Health-System Pharmacists Leadership Award for her efforts and 2025 Distinguished Alumnus Award from the UCSF Pharmacy Alumni Association.

Adriene Zook, Pharm.D., is pharmacy manager of ambulatory clinical pharmacy programs at Geisinger. Dr. Zook graduated from Philadelphia College of Pharmacy, earning a Pharm.D. in 2011. She began her career at Geisinger Health System as a graduate extern, then became a licensed clinical pharmacist, and joined the Geisinger Montoursville Family Practice site; she began Medication Therapy Disease Management services and remained for nearly 9 years, until she took the regional manager position for ambulatory programs in the Geisinger central region. After a leadership restructure, she now has oversight over the entire Family Practice Ambulatory Pharmacy program and assists over 40 clinical pharmacists embedded within 30 primary care locations with program growth and development, day-to-day workflow tasks and requirements, and quality and data tracking tasks. Through her role as a residency preceptor for the administration rotation with both the ambulatory and HSPAL residency programs, Dr. Zook continues to capture her passion for education for her providers, pharmacists, and pharmacy learners. She has recently found a niche in which to grow her research knowledge, working with the Geisinger innovations team on quality grant initiatives for the population health strategic priorities within the health system. She is pursuing an M.B.A. from Western Governors University with an anticipated graduation in fall 2025.

This page intentionally left blank.